Apyx Medical Corporation
USD4.71
+0.02 (+0.43%)
CEO
Charles D. Goodwin
IPO Date
2019-01-02
Sector
Healthcare
Industry
Medical - Specialties
Exchange
NASDAQ
Country
US
Open
$4.66
Prev. Close
$4.69
Day Low
$4.60
Day High
$4.80
52W Low
$1.59
52W High
$5.08
Market Cap
$0.20B
Volume
0.13M
| -2.4 |
| 31 Dec 2023 | FY | 64.5% | -35.7% | -70.1% | -23.6% | 1.44 | 5.52 | -4.8 |
| 31 Dec 2022 | FY | 65.4% | -52.1% | -61.7% | -44.8% | 0.02 | 3.63 | -3.5 |
| 31 Dec 2021 | FY | 69.3% | -31.3% | -28.3% | -22.1% | 0.01 | 4.60 | -29.0 |
| 31 Dec 2020 | FY | 63.2% | -42.9% | -18.7% | -16.1% | 0.01 | 7.22 | -20.7 |
| 31 Dec 2019 | FY | 67.6% | -69.8% | -27.7% | -23.3% | 0.02 | 6.26 | -14.6 |
| 31 Dec 2018 | FY | 64.7% | 383.6% | 72.9% | 66.9% | 0.00 | 11.62 | 3.4 |
| 31 Dec 2017 | FY | 50.8% | -13.0% | -23.0% | -16.3% | 0.13 | 3.77 | -40.2 |
| 31 Dec 2016 | FY | 48.9% | -10.8% | -15.1% | -11.3% | 0.12 | 5.03 | -44.9 |
| -28.4 |
| 30 Sept 2025 | Q3 | 64.4% | -15.4% | -33.9% | -3.5% | 6.71 | 4.44 | -11.0 |
| 30 Jun 2025 | Q2 | 62.3% | -33.2% | -52.1% | -6.5% | 5.39 | 4.72 | -6.1 |
| 31 Mar 2025 | Q1 | 60.1% | -44.0% | -39.5% | -6.9% | 3.70 | 5.45 | -2.9 |
| 31 Dec 2024 | Q4 | 63.0% | -32.5% | -32.6% | -7.1% | 2.73 | 5.26 | -3.3 |
| 30 Sept 2024 | Q3 | 60.5% | -40.9% | -42.6% | -7.7% | 3.52 | 5.46 | -2.3 |
| 30 Jun 2024 | Q2 | 23.1% | -54.0% | -44.5% | -10.0% | 2.62 | 5.33 | -1.7 |
| 31 Mar 2024 | Q1 | 58.1% | -74.0% | -37.4% | -10.7% | 1.91 | 5.87 | -1.6 |
| 31 Dec 2023 | Q4 | 27.7% | -65.5% | -36.0% | -12.1% | 1.44 | 5.52 | -2.4 |